EUCOPE News

News - June 22, 2018

Joint pharmaceutical industry statement on the Commission’s proposal for a Regulation on health technology assessment (HTA)

The pharmaceutical industry represented by AESGP[1], EFPIA[2], EUCOPE[3], EuropaBio[4], Medicines for Europe and PPTA[5] – henceforth referred to as ‘the pharmaceutical industry’ – generally welcomes the European Commission (EC)’s Proposal for a Regulation on HTA[6]. We understand the scope of the joint clinical assessments foreseen… read more

News - March 23, 2018

Associations representing the European and British life science industry respond to the European Council approving terms of the transition period agreed between the UK Government and EU

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today responded to the European Council approving terms of the transition period agreed between the UK Government and EU. Statement… read more

News - December 14, 2017

Joint policy document on the potential impact of the UK’s exiting the EU by the associations representing the European and British life science industry

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exiting the European Union. Abstract The… read more

News - December 14, 2017

EUCOPE and other associations representing the European and British life science industry launch a joint policy document on the potential impact of the UK’s exiting the EU

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exiting the European Union. Today, organisations… read more

News - September 12, 2017

Joint policy document on the potential impact of the UK’s exiting the EU by the associations representing the European and British life science industry

The associations representing the European and British life science industry (AESGP, ABPI, BIA, BGMA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exiting the European Union. Abstract The… read more